Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000251.3(MSH2):c.2211-2A>C variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★★).
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-47478270-A-C is Pathogenic according to our data. Variant chr2-47478270-A-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 90929.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47478270-A-C is described in Lovd as [Likely_pathogenic].
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The splice acceptor variant c.2211-2A>C in MSH2 (NM_000251.3) has been previously reported in affected individuals (Zhang Li et al). The variant has been classified as Likely Pathogenic in ClinVar by an expert review panel. The c.2211-2A>C variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant affects an invariant splice site and hence is expected to cause protein truncation. For these reasons, this variant has been classified as Likely Pathogenic. -
Lynch syndrome Pathogenic:1
Jun 21, 2019
International Society for Gastrointestinal Hereditary Tumours (InSiGHT)
Significance: Likely pathogenic
Review Status: reviewed by expert panel
Collection Method: curation
Interrupts canonical donor splice site -
not provided Pathogenic:1
May 27, 2022
Clinical Genetics Laboratory, Skane University Hospital Lund
Significance: Likely pathogenic
Review Status: criteria provided, single submitter